Expand All | Collapse All

Postgraduate Course: Interventional Hepatology

13 February 2009 (Friday)

08:30 - 10:00	:	Postgraduate Course 1 - Imaging in Clinical Hepatology 08:30 - 08:50 MRI of HCC using Contrast Agents at 3T Byung Ihn Choi, Seoul, Korea 08:50 - 09:10 Perfusion and Diffusion MRI of Liver Masses Jing-Bo Zhang, Hong Kong 09:10 - 09:30 Current Status of Chemoembolisation for HCC Kai-Ping Wong, Sydney, Australia 09:30 - 09:50 Interventional Oncology of HCC: Strategies and Future Shih-Chang Wong, Sydney, Australia 09:50 - 10:00 Discussion Chairperson: Shih-Chang Wang, Sydney
10:15 - 11:45	:	Postgraduate Course 2 - Portal Hypertension and Management Chairperson: Shiv K. Sarin, New Delhi, India
11:45 - 13:15	:	Industry Supported Satellite Symposium
13:15 - 14:45	:	Postgraduate Course 3 - Role of Clinical Hepatologist in HCC 13:15 - 13:35 RFA in Small HCC: Combine Ethanol Injection, Artifcial Ascites and Pleural Effusion Shi-Ming Lin, Taipei 13:35 - 13:55 RFA in Large HCC: Novel Technique Min-Hua Chen, Beijing 13:55 - 14:15 Multi-modalities Treatment in Advanced HCC Masatoshi Tanaka, Kurume, Japan 14:15 - 14:35 Predictors and Prevention of HCC Recurrence after Curative Ablation Ryosuke Tateishi, Tokyo, Japan 14:35 - 14:45 Discussion Chairperson: Shi-Ming Lin, Taipei
15:00 - 16:30	:	Postgraduate Course 4 - Pathology 15:00 - 15:20 Bile Duct Pathology Yasuni Nakanuma, Kanazawa, Japan 15:20 - 15:40 Pathology of Liver Cancer Young-Nyun Park, Seoul, Korea 15:40 - 16:00 Steatohepatitis Alastair D. Burt, Newcastle, United Kingdom 16:00 - 16:20 Viral Hepatitis Man-Shan Tsui, Hong Kong 16:20 - 16:30 Discussion Chairperson: Siu-Tsan Yuen, Hong Kong
16:30 - 18:30	:	Postgraduate Course 5 - Liver Transplantation 16:30 - 16:50 Management of Viral Hepatitis after Liver Transplantation TBC 16:50 - 17:10 Selection Criteria for Liver Transplantation: Utilization of the MELD Score and its Clinical Application Robert G. Gish, San Francisco, United States 17:10 - 17:30 Patient Selection with Hepatocellular Carcinoma for Liver Transplantation TBC 17:30 - 17:50 Post Liver Transplantation: Management of Complications and Immunosuppression John J. Fung, Cleveland, United States 17:50 - 18:10 Living Donor Liver Transplantation in the Asia Pacific Region Chung-Mao Lo, Hong Kong 18:10 - 18:30 Discussion Chairperson: John J. Fung, Cleveland, United States Robert G. Gish, San Francisco, United States
18:30 - 20:00	:	Faculty Dinner

 

3-day Core Program

14 February 2009 (Saturday)

08:30 - 09:00	:	Morning Session 1 - Basic Research in HBV 08:00 - 08:30 Chien-Jen Chen, Taipei 08:00 - 08:30 Chun-Jen Lin, Taipei
08:30 - 09:00	:	Morning Session 2 - Challenges in HCV Treatment 08:00 - 08:30 W. Graham Cooksley, Brisbane, Australia 08:00 - 08:30 Hirohito Tsubouchi, Kagoshima, Japan
08:30 - 09:00	:	Morning Session 3 - Approach to Treatment of HCC 08:00 - 08:30 Chi-Leung Liu, Hong Kong 08:00 - 08:30 Soek-Siam Tan, Kuala Lumpur, Malaysia
08:30 - 09:00	:	Morning Session 4 - Infection and the Liver 08:00 - 08:30 Yogesh K. Chawla, Chandigarh, India 08:00 - 08:30 Saeed Hamid, Karachi, Pakistan
09:00 - 10:30	:	Industry Supported Satellite Symposia
10:30 - 11:00	:	Opening Ceremony
11:00 - 11:30	:	Presidential Lecture 11:00 - 11:30 Management of Chronic Hepatitis B Infection in Asia-Pacific Region - 2009 and Beyond George K.K. Lau, Hong Kong Chairperson: Masao Omata, Tokyo, Japan
11:30 - 12:00	:	Kunio Okuda Lecture 11:30 - 12:00 Liver Transplantation for HCC Shueng-Tat Fan, Hong Kong
12:00 - 12:30	:	Exhibition and Poster Opening
12:30 - 14:00	:	Industry Supported Satellite Symposia
14:00 - 14:30	:	Exhibition and Poster Viewing
14:00 - 15:00	:	APASL Consensus on HCC
14:30 - 15:30	:	Plenary Presentation 1 Chairperson: Scott L. Friedman, New York, United States Ji-Dong Jia, Beijing
15:00 - 18:30	:	APASL-China Symposium: The Development of HCC in Viral Hepatitis
15:30 - 17:00	:	Concurrent Session 1 - HCV Treatment 15:30 - 15:50 New Molecules for HCV Treatment John G. McHutchison, Durham, United States 15:50 - 16:10 Approach to Difficult-to-treat Patients Robert G. Gish, San Francisco, United States 16:10 - 16:30 Gene Therapy in HCV Lai Wei, Beijing 16:30 - 16:50 Impact of HCV Genotype and Treatment Regime Peter Ferenci, Vienna, Austria Chairperson: Wilson W.C. Lao, Hong Kong Yoshiyuki Ueno, Seiryo, Japan
15:30 - 17:00	:	Concurrent Session 2 - Controversy in Guidelines of HBV 15:30 - 15:50 Start Treatment for Low ALT - Pros Nancy W.Y. Leung, Hong Kong 15:50 - 16:10 Start Treatment for Low ALT - Cons Wan-Cheng Chow, Singapore 16:10 - 16:30 Nucleos(t)ide Analog Can Be Stopped - Pros Ji-Dong Jia, Beijing 16:30 - 16:50 Nucleos(t)ide Analog Can Be Stopped - Cons Eugene R. Schiff, Miami, United States Chairperson: Xiao-Hui Miao, Shanghai Thomas S.T. Lai Hong Kong
15:30 - 17:00	:	Concurrent Session 3 - HCC Prevention and Surveillance 15:30 - 15:50 Epidemiology of HCC in Asia Pacific Man-Fung Yuen, Hong Kong 15:50 - 16:10 Prevention of HCC - Is It Possible Seng-Gee Lim, Singapore 16:10 - 16:30 Role of HCC Surveillance Deepak N. Amarapurkar, Mumbai, India 16:30 - 16:50 Recommendation on the Surveillance Program for HBV and HCV Kwang-Hyub Han, Seoul, Korea Chairperson: Jin-Lin Hou, Guangzhou Rosmawati Mohamed Kuala Lumpur, Malaysia
17:00 - 18:30	:	Free Paper Presentation
17:00 - 18:30	:	Young Invesitgator Presentation 1 Chairperson: David A. Brenner, La Jolla, United States Seng-Gee Lim, Singapore
18:30 - 20:00	:	Cultural Night

15 February 2009 (Sunday)

08:00 - 08:30	:	Morning Session 5 - Controversy in HBV Treatment 08:00 - 08:30 Jun Cheng, Beijing 08:00 - 08:30 Eng-Kiong Teo, Singapore
08:00 - 08:30	:	Morning Session 6 - Acute Viral Hepatitis 08:00 - 08:30 Mun-Hon Ng, Xiamen 08:00 - 08:30 Guang-Feng Shi, Shanghai
08:00 - 08:30	:	Morning Session 7 - Role of Imaging in Liver Diseases 08:00 - 08:30 Garrett C.L. Ho, Hong Kong 08:00 - 08:30 Simon C.H. Yu, Hong Kong
08:00 - 08:30	:	Morning Session 8 - Basic Research in Fatty Liver Diseases 08:00 - 08:30 Nurdan Tozun, Istanbul, Turkey 08:00 - 08:30 Jun Yu, Hong Kong
08:30 - 10:00	:	Industry Supported Satellite Symposium
10:00 - 11:30	:	Editors Forum: Experts' Tips on Publication 10:30 - 10:50 How to Prepare a Manscript for Submission Masao Omata, Tokyo, Japan 10:50 - 11:10 Tips to Submit a Basic Research Paper Massimo Colombo, Milan, Italy 11:10 - 11:30 Medical Ethics for Clinical Studies Patrick S. Kamath Rochester, United States 11:30 - 11:50 Tips to Submit a Clinical Research Paper Samuel S. Lee, Calgary, Canada Chairperson: Khean-Lee Goh, Kuala Lumpur, Malaysia Nancy W. Y. Leung, Hong Kong
10:00 - 10:30	:	State-of-the-Art Lecture 1 10:30 - 11:00 Advances in Hepatitis C Infection Michael P. Manns Hannover, Germany Chairperson: George K.K. Lau, Hong Kong
10:30 - 11:00	:	State-of-the-Art Lecture 2 11:00 - 11:30 Acute Liver Failure Roger S. Williams, London, United Kingdom Chairperson: Hyo-Suk Lee, Seoul
11:00 - 11:30	:	State-of-the-Art Lecture 3 11:30 - 12:00 The Insight of Human Liver Proteome Project Fu-Chu He, Beijing Chairperson: Laurentius A. Lesmana, Jakarta, Indonesia
11:30 - 12:30	:	Debate on HBV Treatment Guideline: AASLD, APASL and EASL
12:30 - 14:00	:	Industry Supported Satellite Symposium
14:00 - 14:30	:	Exhibition & Poster Viewing
14:00 - 18:30	:	Falk Workshop: Autoimmune Hepatitis and Overlap Syndromes - East meets West
14:30 - 15:30	:	Plenary Presentation 2 Chairperson: Stephen A. Locarnini, North Melbourne, Australia Anna S.F. Lok, Ann Abor, United States
15:30 - 17:00	:	Concurrent Session 4 - HBV Treatment 15:30 - 15:50 How to Choose between PegIFN and Nucleoside Analogues Harry L.A. Janssen, Rotterdam, Netherlands 15:50 - 16:10 Is Combination Treatment Superior to Monotherapy? Anna S.F. Lok Ann Arbor, United States 16:10 - 16:30 How will Tenofovir Change the Choice of Anti-viral Agents Patrick Marcellin, Clichy, France 16:30 - 16:50 Is There Any Loophole in the Roadmap Model? Edward J. Gane, Auckland, New Zealand Chairperson: Jun Cheng, Beijing Jak-Yiu Lai, Hong Kong
15:30 - 17:00	:	Concurrent Session 5 - Liver Fibrosis 15:30 - 15:50 Non-invasive Tests of Liver Fibrosis Gui-Qiang Wang, Beijing 15:50 - 16:10 Reversibility of Liver Fibrosis Teerha Piratvisuth, Hat Yai, Thailand 16:10 - 16:30 Reactive Oxygen Species and Liver Fibrosis Ramón Bataller, Barcelona, Spain 16:30 - 16:50 Intestinal Permeability, Innate Immunity and Liver Fibrosis David A. Brenner, La Jolla, United States Chairperson: Ching-Kong Loo, Hong Kong Chutima Pramoolsinsap, Bangkok, Thailand
15:30 - 17:30	:	Concurrent Session 6 - Virology 15:30 - 15:50 The Role of HCV RNA Monitoring Ming-Lung Yu, Kaohsiung 15:50 - 16:10 The Role of HBV RNA Monitoring Jean-Michel Pawlotsky, Creteil, France 16:10 - 16:30 The Role of HBV Resistance Monitoring Scott Bowden, Melbourne, Australia 16:30 - 16:50 The Role of Quantitative HBsAg Measurement Jin-Lin Hou, Guangzhou Chairperson: Yee-Tak Hui, Hong Kong Guang-Feng Shi, Shanghai
17:00 - 18:30	:	Free Paper Presentations
17:00 - 18:30	:	Young Investigator Presentation 2 Chairperson: Hsiang-Fu Kung, Hong Kong Jean-Michel Pawlotsky, Creteil, France
18:30 - 20:00	:	Industry Supported Satellite Symposium

16 February 2009 (Monday)

08:00 - 08:30	:	Morning Session 9 - Drug Induced Liver Disease 08:00 - 08:30 Tai-Nin Chau, Hong Kong 08:00 - 08:30 Xiao-Hui Miao, Shanghai
08:00 - 08:30	:	Morning Session 10 - Liver Transplantation 08:00 - 08:30 John J. Fung, Cleveland, United States 08:00 - 08:30 Mobin Khan, Dhaka, Bangladesh
08:00 - 08:30	:	Morning Session 11 - Basic Research in HCC 08:00 - 08:30 Ming-Liang He, Hong Kong 08:00 - 08:30 Qin Ning, Wuhan
08:00 - 08:30	:	Morning Session 12 - Clinical NAFLD 08:00 - 08:30 Shivakumar Chitturi, Canberra, Australia 08:00 - 08:30 Jose D. Sollano, Manila, Philippines
08:30 - 15:30	:	USJMSCP-NIH-APASL Joint Symposium - HBV Antiviral Resistance Chairperson: Rajen Koshy, Bethesda, United States Seng-Gee Lim, Singapore Anna S.F. Lok, Ann Arbor, United States Masashi Mizokami, Nagoya, Japan
08:45 - 10:15	:	Concurrent Session 7 - Immunology in Viral Hepatitis 08:45 - 09:05 Update on HBV Vaccine Mei-Hwei Chang, Taipei 09:05 - 09:20 CTL Response to HBV Fu-Sheng Wang, Beijing 09:20 - 09:40 Innate Immune Response in HBV Stephen A. Locarnini, North Melbourne, Australia 09:40 - 10:00 Immune Response to HCV Xin-Xin Zhang, Shanghai Chairperson: Qin Ning, Wuhan Siu-Tsan Yuen, Hong Kong
08:45 - 10:15	:	Concurrent Session 8 - HCC Virology 08:45 - 09:05 HBV Genotypes and HCC Jia-Horng Kao, Taipei 09:05 - 09:20 HCC Asociated HBV Mutants Masashi Mizokami, Nagoya, Japan 09:20 - 09:40 HBx and HCC Irene O.L. Ng, Hong Kong 09:40 - 10:00 HCV and HCC T. Jake Liang, Bethesda, United States Chairperson: Siu-Tim Cheung, Hong Kong Gui-Qiang Wang, Beijing
08:45 - 10:15	:	Concurrent Session 9 - Liver Transplantation 08:45 - 09:05 Patient Selection John J. Fung, Cleveland, United States 09:05 - 09:20 Management of HCV in Liver Transplantation W. Ray Kim, Rochester, United States 09:20 - 09:40 Management of HBV in Liver Transplantation Geoffrey W. McCaughan, Camperdown, Australia 09:40 - 10:00 Management of Post-transplant Complications Chung-Mau Lo, Hong Kong Chairperson: Darrell H.G. Crawford, Brisbane, Australia Chi-Leung Liu, Hong Kong
10:30 - 11:00	:	State-of-the-Art Lecture 4 10:30 - 11:00 HBV and HCC
11:00 - 11:30	:	State-of-the-Art Lecture 5 11:00 - 11:30 The Lesson on HBV Virology from Experimental Models Jörg Petersen, Hamburg, Germany Chairperson: Nurdan Tozun, Istanbul, Turkey
11:30 - 12:00	:	State-of-the-Art Lecture 6 11:30 - 12:00 Evolving Challenges in Hepatic Fibrosis Scott L. Friedman, New York, United States Chairperson: Dong Jin Suh, Seoul, Korea
12:00 - 12:30	:	Exhibition and Poster Viewing
12:30 - 14:00	:	Concurrent Session 10 - Fatty Liver Diseases 12:30 - 12:50 NAFLD in Asia Pacific Region Jian-Gao Fan, Shanghai 12:50 - 13:10 Assessment of NAFLD Vincent W.S. Wong, Hong Kong 13:10 - 13:30 Animal Models of Alcoholism Howard C. Thomas, London, United Kingdom 13:30 - 13:50 Insulin Resistance and HCV Jacob George, Westmead, Australia Chairperson: Shivakumar Chitturi, Canberra, Australia Steven W.C. Tsang, Hong Kong
12:30 - 14:00	:	Concurrent Session 11 - HCV Treatment 12:30 - 12:50 Prophylaxis of HBV Reactivation Winnie Yeo, Hong Kong 12:50 - 13:10 Surgical Treatment for HCC Paul B.S. Lai, Hong Kong 13:10 - 13:30 Targeted Therapy for HCC Massimo Colombo, Milan, Italy 13:30 - 13:50 Locoablative Treatment for HCC Jordi Bruix, Barcelona, Spain Chairperson: Peter Ferenci, Vienna, Austria Edward C.S. Lai, Hong Kong
12:30 - 14:00	:	APASL Working Party - Acute Variceal Bleeding
14:00 - 14:30	:	Exhibition and Poster Viewing
14:30 - 15:30	:	Plenary Presentation 3 Chairperson: Pei-Jer Chen, Taipei Michael P. Manns, Hannover, Germany
15:30 - 17:00	:	Concurrent Session 12 - Liver Cirrhosis and Liver Failure 15:30 - 15:50 Acute on Chronic Liver Failure Shiv K. Sarin, New Delhi, India 15:50 - 16:10 Ascites and SBP Anuchit Chutaputti, Bangkok, Thailand 16:10 - 16:30 Management of Liver Failure Yu-Ming Wang, Chongqing 16:30 - 16:50 Decompensated CHB Robert J. Fontana, Ann Arbor, United States Chairperson: Michael K.K. Li, Hong Kong Hong Ren, Chongqing
15:30 - 17:00	:	Concurrent Session 13 - HCC Basic 15:30 - 15:50 miRNA Nathalie Wong, Hong Kong 15:50 - 16:10 Stem Cell Ronnie T.P. Poon, Hong Kong 16:10 - 16:30 Androgen Receptor Shiou-Hwei Yeh, Taipei 16:30 - 16:50 Molecular markers for HCC Recurrence Hui-Chuan Sun, Shanghai Chairperson: Mobin Khan, Dhaka, Bangladesh Nancy K. Man Hong Kong
15:30 - 17:00	:	Concurrent Session 14 - Pancreatobiliary Disease 15:30 - 15:50 EUS Yuk-Tong Lee, Hong Kong 15:50 - 16:10 PBC vs AIH Michael P. Manns, Hannover, Germany 16:10 - 16:30 PSC and Cholangiocarcinoma Rupert W.L. Leong, Sydney, Australia 16:30 - 16:50 Acute Pancreatitis Paul B.